Regulation of EGF-stimulated activation of the PI-3K/AKT pathway by exocyst-mediated exocytosis

Seong J An1,2, Alexander Anneken1, Zhiqun Xi1

  • 1Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06510.

Insights

The exocyst complex regulates the PI-3K/AKT cell survival pathway in epithelial cells. Exocytosis, mediated by the exocyst, controls PI(3,4,5)P3 levels, impacting AKT activation downstream of EGFR signaling.

Area of Science:

  • Cell Biology
  • Molecular Signaling
  • Cancer Research

Background:

  • The phosphoinositide-3 kinase (PI-3K)/AKT pathway is crucial for cell survival and is activated by epidermal growth factor receptor (EGFR) signaling.
  • The exocyst complex, a key regulator of exocytosis, has not been previously recognized as a component of this pathway in epithelial cells.

Purpose of the Study:

  • To investigate the role of the exocyst complex in regulating the PI-3K/AKT pathway activation by EGFR.
  • To elucidate the mechanism by which exocytosis influences PI(3,4,5)P3 generation and subsequent AKT activation.

Main Methods:

  • Live-cell imaging to observe PI(3,4,5)P3 dynamics at the plasma membrane.
  • Optogenetic manipulation to promote exocytosis and assess its impact on PI-3K/AKT signaling.
  • Pharmacological inhibition (Endosidin2) and genetic knockdown (siRNA) of exocyst subunits to impair exocytosis.
  • Analysis of AKT activation in response to EGF stimulation and EGFR tyrosine kinase inhibitors.

Main Results:

  • PI(3,4,5)P3 levels fluctuate dynamically at the cell membrane, correlating with exocytic events.
  • Enhanced exocytosis via optogenetics increases PI(3,4,5)P3 production and AKT activation.
  • Inhibition of exocyst function impairs EGF-induced PI(3,4,5)P3 generation and AKT activation.
  • Exocyst inhibition prevents spontaneous AKT reactivation during prolonged EGFR inhibition.

Conclusions:

  • Exocyst-mediated exocytosis is a critical regulator of PI-3K/AKT pathway activation in epithelial cells.
  • The exocyst complex controls PI(3,4,5)P3 levels at the plasma membrane, thereby modulating EGFR signaling.
  • Targeting the exocyst complex offers a potential strategy to modulate PI-3K/AKT pathway activity in diseases driven by EGFR signaling.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.6K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K